Correlation Between Crinetics Pharmaceuticals and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Capricor Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Capricor Therapeutics.
Diversification Opportunities for Crinetics Pharmaceuticals and Capricor Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Crinetics and Capricor is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Capricor Therapeutics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.56 times more return on investment than Capricor Therapeutics. However, Crinetics Pharmaceuticals is 1.79 times less risky than Capricor Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 5,715 in Crinetics Pharmaceuticals on August 29, 2024 and sell it today you would lose (38.00) from holding Crinetics Pharmaceuticals or give up 0.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Capricor Therapeutics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Capricor Therapeutics |
Crinetics Pharmaceuticals and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Capricor Therapeutics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |